The EVER proteins as a natural barrier against papillomaviruses: A new insight into the pathogenesis of human papillomavirus infections

Microbiology and Molecular Biology Reviews

Volumn 73, Issue 2, 2009, Pages 348-370

  Lazarczyk, Maciej ^a,b,c,d   Cassonnet, Patricia ^a   Pons, Christian ^a   Jacob, Yves ^a   Favre, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b France   (France)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EVER PROTEIN; GLYCOPROTEIN E2; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZINC; ZINC TRANSPORTER;

EPIDERMODYSPLASIA VERRUCIFORMIS; EVER GENE; EVER1 GENE; EVER2 GENE; FOCAL EPITHELIUM HYPERPLASIA; GENE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS BETA; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PAPILLOMA VIRUS; PROTEIN PROTEIN INTERACTION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION; VIRUS INHIBITION; VIRUS PATHOGENESIS; WHIM SYNDROME; ZINC METABOLISM;

CATION TRANSPORT PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; MEMBRANE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS; UTERINE CERVICAL NEOPLASMS; ZINC;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 66749181287     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.00033-08     Document Type: Review

References (237)

1. Akgul, B., M. Curten, H. Haigis, I. Rogosz, and H. Pfister. 2006. Interferon regulatory factor 5.2 acts as a transcription repressor of epidermodysplasia verruciformis-associated human papillomaviruses. Arch. Virol. 151:2461-2473.
2. Andrews, G. K., H. Wang, S. K. Dey, and R. D. Palmiter. 2004. Mouse zinc transporter 1 gene provides an essential function during early embryonic development. Genesis 40:74-81.
3. Androphy, E. J., I. Dvoretzky, and D. R. Lowy. 1985. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch. Dermatol. 121:864-868.
4. Antonsson, A., O. Forslund, H. Ekberg, G. Sterner, and B. G. Hansson. 2000. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641. (Pubitemid 32222312)
5. Antonsson, A., S. Karanfilovska, P. G. Lindqvist, and B. G. Hansson. 2003. General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 41:2509-2514.
6. Anttila, P. H., E. von Willebrand, and O. Simell. 1986. Abnormal immune responses during hypozincaemia in acrodermatitis enteropathica. Acta Paediatr. Scand. 75:988-992.
7. Ashrafi, G. H., M. Haghshenas, B. Marchetti, and M. S. Campo. 2006. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119:2105-2112.
8. Auf der Maur, A., T. Belser, Y. Wang, C. Gunes, P. Lichtlen, O. Georgiev, and W. Schaffner. 2000. Characterization of the mouse gene for the heavy metal-responsive transcription factor MTF-1. Cell Stress Chaperones 5:196-206.
9. Ault, K. A. 2006. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol. 2006(Suppl.):40470.
10. Azzimonti, B., M. Mondini, M. De Andrea, D. Gioia, U. Dianzani, R. Mesturini, G. Leigheb, R. Tiberio, S. Landolfo, and M. Gariglio. 2005. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch. Dermatol. 141:1323-1325.
11. Bachmann, M. F., A. Gallimore, S. Linkert, V. Cerundolo, A. Lanzavecchia, M. Kopf, and A. Viola. 1999. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J. Exp. Med. 189:1521-1530.
12. Balabanian, K., B. Lagane, J. L. Pablos, L. Laurent, T. Planchenault, O. Verola, C. Lebbe, D. Kerob, A. Dupuy, O. Hermine, J. F. Nicolas, V. Latger-Cannard, D. Bensoussan, P. Bordigoni, F. Baleux, F. Le Deist, J. L. Virelizier, F. Arenzana-Seisdedos, and F. Bachelerie. 2005. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 105:2449-2457. (Pubitemid 40387045)
13. Balabanian, K., A. Levoye, L. Klemm, B. Lagane, O. Hermine, J. Harriague, F. Baleux, F. Arenzana-Seisdedos, and F. Bachelerie. 2008. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J. Clin. Investig. 118:1074-1084.
14. Barbosa, M. S., D. R. Lowy, and J. T. Schiller. 1989. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J. Virol. 63:1404-1407. (Pubitemid 19061382)
15. Barthel, A., E. A. Ostrakhovitch, P. L. Walter, A. Kampkotter, and L. O. Klotz. 2007. Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch. Biochem. Biophys. 463:175-182.
16. Beaudenon, S., F. Praetorius, D. Kremsdorf, M. Lutzner, N. Worsaae, G. Pehau-Arnaudet, and G. Orth. 1987. A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J. Investig. Dermatol. 88:130-135.
17. Berger, N. A., and A. M. Skinner. 1974. Characterization of lymphocyte transformation induced by zinc ions. J. Cell Biol. 61:45-55.
18. Bernard, H. U. 2005. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J. Clin. Virol. 32(Suppl. 1):S1-S6.
19. Bernard, H. U., and D. Apt. 1994. Transcriptional control and cell type specificity of HPV gene expression. Arch. Dermatol. 130:210-215.
20. Bouwes Bavinck, J. N., E. I. Plasmeijer, and M. C. Feltkamp. 2008. Betapapillomavirus infection and skin cancer. J. Investig. Dermatol. 128:1355-1358.
21. Braakhuis, B. J., P. J. Snijders, and C. R. Leemans. 2007. Human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 357:1157; author reply 1157-1158.
22. Bravo, I. G., and A. Alonso. 2004. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J. Virol. 78:13613-13626. (Pubitemid 39612761)
23. Bravo, I. G., and A. Alonso. 2007. Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins. Virus Genes 34:249-262. (Pubitemid 46474927)
24. Burk, R. D., M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, R. Mortel, P. E. Schwartz, and A. Hildesheim. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 63:7215-7220. (Pubitemid 37413460)
25. Caldeira, S., I. Zehbe, R. Accardi, I. Malanchi, W. Dong, M. Giarre, E. M. de Villiers, R. Filotico, P. Boukamp, and M. Tommasino. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77:2195-2206. (Pubitemid 36110032)
26. Castellsague, X., M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, S. Franceschi, R. W. Peeling, R. Ashley, J. S. Smith, P. J. Snijders, C. J. Meijer, and F. X. Bosch. 2006. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98:303-315.
27. Chang, J. L., Y. P. Tsao, D. W. Liu, S. J. Huang, W. H. Lee, and S. L. Chen. 2001. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J. Biomed. Sci. 8:206-213.
28. Cheng, S., D. C. Schmidt-Grimminger, T. Murant, T. R. Broker, and L. T. Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
29. Chesters, P. M., K. H. Vousden, C. Edmonds, and D. J. McCance. 1990. Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells. J. Gen. Virol. 71:449-453.
30. Chong, T., D. Apt, B. Gloss, M. Isa, and H. U. Bernard. 1991. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J. Virol. 65:5933-5943.
31. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
32. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178. (Pubitemid 23277529)
33. Cuberos, V., J. Perez, C. J. Lopez, F. Castro, L. V. Gonzalez, L. A. Correa, G. Sanclemente, A. Gaviria, M. Muller, and G. I. Sanchez. 2006. Molecular and serological evidence of the epidemiological association of HPV 13 with focal epithelial hyperplasia: a case-control study. J. Clin. Virol. 37:21-26.
34. Dardenne, M., W. Savino, S. Berrih, and J. F. Bach. 1985. A zinc-dependent epitope on the molecule of thymulin, a thymic hormone. Proc. Natl. Acad. Sci. USA 82:7035-7038.
35. de Koning, M. N., L. Struijk, J. N. Bavinck, B. Kleter, J. ter Schegget, W. G. Quint, and M. C. Feltkamp. 2007. Betapapillomaviruses frequently persist in the skin of healthy individuals. J. Gen. Virol. 88:1489-1495.
36. Dell'oste, V., B. Azzimonti, M. De Andrea, M. Mondini, E. Zavattaro, G. Leigheb, S. J. Weissenborn, H. Pfister, K. M. Michael, T. Waterboer, M. Pawlita, A. Amantea, S. Landolfo, and M. Gariglio. 2009. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J. Investig. Dermatol. 129:1026-1034.
37. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
38. DiMaio, D., and J. B. Liao. 2006. Human papillomaviruses and cervical cancer. Adv. Virus Res. 66:125-159.
39. Doorbar, J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (London) 110:525-541.
40. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32(Suppl. 1):S7-S15.
41. Doorbar, J. 2007. Papillomavirus life cycle organization and biomarker selection. Dis. Markers 23:297-313. (Pubitemid 47015790)
42. Doorbar, J., S. Ely, J. Sterling, C. McLean, and L. Crawford. 1991. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352:824-827. (Pubitemid 21912441)
43. Driessen, C., K. Hirv, L. Rink, and H. Kirchner. 1994. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphok. Cytok. Res. 13:15-20.
44. D'Souza, G., A. R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W. M. Koch, W. H. Westra, and M. L. Gillison. 2007. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356:1944-1956.
45. Duensing, S., L. Y. Lee, A. Duensing, J. Basile, S. Piboonniyom, S. Gonzalez, C. P. Crum, and K. Munger. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA 97:10002-10007.
46. Dunne, E. F., E. R. Unger, M. Sternberg, G. McQuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz. 2007. Prevalence of HPV infection among females in the United States. JAMA 297:813-819. (Pubitemid 46333946)
47. Egawa, K. 2003. Do human papillomaviruses target epidermal stem cells? Dermatology 207:251-254.
48. Eide, D. J. 2006. Zinc transporters and the cellular trafficking of zinc. Biochim. Biophys. Acta 1763:711-722.
49. Elgui de Oliveira, D. 2007. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett. 247:182-196.
50. Eom, S. J., E. Y. Kim, J. E. Lee, H. J. Kang, J. Shim, S. U. Kim, B. J. Gwag, and E. J. Choi. 2001. Zn(2+) induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-kinase. Mol. Pharmacol. 59:981-986.
51. Favre, M., F. Breitburd, O. Croissant, and G. Orth. 1977. Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J. Virol. 21:1205-1209. (Pubitemid 8163126)
52. Favre, M., S. Majewski, B. Noszczyk, F. Maienfisch, A. Pura, G. Orth, and S. Jablonska. 2000. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J. Investig. Dermatol. 114:403-407.
53. Favre, M., G. Orth, S. Majewski, S. Baloul, A. Pura, and S. Jablonska. 1998. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J. Investig. Dermatol. 110:311-317.
54. Favre, M., N. Ramoz, and G. Orth. 1997. Human papillomaviruses: general features. Clin. Dermatol. 15:181-198.
55. Fernandes, G., M. Nair, K. Onoe, T. Tanaka, R. Floyd, and R. A. Good. 1979. Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc. Natl. Acad. Sci. USA 76:457-461.
56. Forslund, O., A. Antonsson, P. Nordin, B. Stenquist, and B. G. Hansson. 1999. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J. Gen. Virol. 80:2437-2443.
57. Forslund, O., T. Iftner, K. Andersson, B. Lindelof, E. Hradil, P. Nordin, B. Stenquist, R. Kirnbauer, J. Dillner, and E. M. de Villiers. 2007. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J. Infect. Dis. 196:876-883.
58. Fraker, P. J., and L. E. King. 2004. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 24:277-298.
59. Frattini, M. G., and L. A. Laimins. 1994. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. USA 91:12398-12402.
60. Frattini, M. G., and L. A. Laimins. 1994. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204:799-804. (Pubitemid 24330886)
61. Frisch, M. 2002. On the etiology of anal squamous carcinoma. Dan. Med. Bull. 49:194-209.
62. Garcia-Vallve, S., A. Alonso, and I. G. Bravo. 2005. Papillomaviruses: different genes have different histories. Trends Microbiol. 13:514-521. (Pubitemid 41506892)
63. Gaspar, H. B., C. Harwood, I. Leigh, and A. J. Thrasher. 2004. Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency. Br. J. Haematol. 127:232-233.
64. Gewirtzman, A., B. Bartlett, and S. Tyring. 2008. Epidermodysplasia verruciformis and human papilloma virus. Curr. Opin. Infect. Dis. 21:141-146.
65. Giannoudis, A., and C. S. Herrington. 2001. Human papillomavirus variants and squamous neoplasia of the cervix. J. Pathol. 193:295-302. (Pubitemid 32229859)
66. Giroglou, T., L. Florin, F. Schafer, R. E. Streeck, and M. Sapp. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75:1565-1570. (Pubitemid 32094716)
67. Giuliano, A. R., B. Lu, C. M. Nielson, R. Flores, M. R. Papenfuss, J. H. Lee, M. Abrahamsen, and R. B. Harris. 2008. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J. Infect. Dis. 198:827-835.
68. Glinski, W., S. Jablonska, A. Langner, S. Obalek, M. Haftek, and M. Proniewska. 1976. Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica 153:218-227.
69. Glinski, W., S. Obalek, S. Jablonska, and G. Orth. 1981. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica 162:141-147. (Pubitemid 11105838)
70. Goldschmidt, M. H., J. S. Kennedy, D. R. Kennedy, H. Yuan, D. E. Holt, M. L. Casal, A. M. Traas, E. A. Mauldin, P. F. Moore, P. S. Henthorn, B. J. Hartnett, K. I. Weinberg, R. Schlegel, and P. J. Felsburg. 2006. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J. Virol. 80:6621-6628. (Pubitemid 43927464)
71. Gottschling, M., A. Stamatakis, I. Nindl, E. Stockfleth, A. Alonso, and I. G. Bravo. 2007. Multiple evolutionary mechanisms drive papillomavirus diversification. Mol. Biol. Evol. 24:1242-1258.
72. Grossman, S. R., and L. A. Laimins. 1989. E6 protein of human papillomavirus type 18 binds zinc. Oncogene 4:1089-1093. (Pubitemid 19211723)
73. Gulino, A. V., D. Moratto, S. Sozzani, P. Cavadini, K. Otero, L. Tassone, L. Imberti, S. Pirovano, L. D. Notarangelo, R. Soresina, E. Mazzolari, D. L. Nelson, L. D. Notarangelo, and R. Badolato. 2004. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 104:444-452. (Pubitemid 38900027)
74. Haase, H., and W. Maret. 2003. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 291:289-298.
75. Harwood, C. A., T. Surentheran, J. M. McGregor, P. J. Spink, I. M. Leigh, J. Breuer, and C. M. Proby. 2000. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J. Med. Virol. 61:289-297.
76. Harwood, C. A., T. Surentheran, P. Sasieni, C. M. Proby, C. Bordea, I. M. Leigh, F. Wojnarowska, J. Breuer, and J. M. McGregor. 2004. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br. J. Dermatol. 150:949-957.
77. Hazard, K., K. Andersson, J. Dillner, and O. Forslund. 2007. Human papillomavirus subtypes are not uncommon. Virology 362:6-9. (Pubitemid 46617701)
78. Hebert, A. A., and M. D. Lopez. 1997. Oral lesions in pediatric patients. Adv. Dermatol. 12:169-193; discussion 194.
79. Hebner, C. M., and L. A. Laimins. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
80. Heck, D. V., C. L. Yee, P. M. Howley, and K. Munger. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89:4442-4446.
81. Herbein, G., A. Varin, and T. Fulop. 2006. NF-kappaB, AP-1, zinc-deficiency and aging. Biogerontology 7:409-419.
82. Hernandez, P. A., R. J. Gorlin, J. N. Lukens, S. Taniuchi, J. Bohinjec, F. Francois, M. E. Klotman, and G. A. Diaz. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34:70-74.
83. Hess, J., P. Angel, and M. Schorpp-Kistner. 2004. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117:5965-5973. (Pubitemid 40123963)
84. Heuchel, R., F. Radtke, O. Georgiev, G. Stark, M. Aguet, and W. Schaffner. 1994. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J. 13:2870-2875. (Pubitemid 24191697)
85. Hildesheim, A., R. Herrero, P. E. Castle, S. Wacholder, M. C. Bratti, M. E. Sherman, A. T. Lorincz, R. D. Burk, J. Morales, A. C. Rodriguez, K. Helgesen, M. Alfaro, M. Hutchinson, I. Balmaceda, M. Greenberg, and M. Schiffman. 2001. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br. J. Cancer 84:1219-1226. (Pubitemid 32511340)
86. Horn, S., H. Pfister, and P. G. Fuchs. 1993. Constitutive transcriptional activator of epidermodysplasia verruciformis-associated human papillomavirus 8. Virology 196:674-681. (Pubitemid 23283465)
87. Huh, K., X. Zhou, H. Hayakawa, J. Y. Cho, T. A. Libermann, J. Jin, J. W. Harper, and K. Munger. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81:9737-9747. (Pubitemid 350067678)
88. Huse, M., M. J. Eck, and S. C. Harrison. 1998. A Zn2+ ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck. J. Biol. Chem. 273:18729-18733.
89. Iversen, T., and S. Tretli. 1998. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet. Gynecol. 91:969-972.
90. Jablonska, S., J. Dabrowski, and K. Jakubowicz. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 32:583-589.
91. Jackson, S., L. Ghali, C. Harwood, and A. Storey. 2002. Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br. J. Cancer 87:319-323.
92. Jackson, S., C. Harwood, M. Thomas, L. Banks, and A. Storey. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14:3065-3073.
93. Jamieson, D. J., P. Paramsothy, S. Cu-Uvin, A. Duerr, and the HIV Epidemiology Research Study Group. 2006. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet. Gynecol. 107:1023-1028.
94. Joyce, J. G., J. S. Tung, C. T. Przysiecki, J. C. Cook, E. D. Lehman, J. A. Sands, K. U. Jansen, and P. M. Keller. 1999. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274:5810-5822.
95. Kabsch, K., and A. Alonso. 2002. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J. Virol. 76:12162-12172. (Pubitemid 35304314)
96. Kalantari, M., L. L. Villa, I. E. Calleja-Macias, and H. U. Bernard. 2008. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int. J. Cancer 123:1832-1840.
97. Kanda, T., S. Watanabe, S. Zanma, H. Sato, A. Furuno, and K. Yoshiike. 1991. Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif. Virology 185:536-543.
98. Kang, J. H., S. W. Jin, H. S. Yoon, W. D. Yoo, H. S. Kim, K. S. Hahm, and S. N. Park. 1997. Analysis of the conformational change of recombinant human papilloma virus type 18 E7 protein induced by metal binding. Virus Res. 49:147-154. (Pubitemid 27252783)
99. Kappes, D. J. 2007. CD4 and CD8: hogging all the Lck. Immunity 27:691-693. (Pubitemid 350102261)
100. Kawai, T., U. Choi, N. L. Whiting-Theobald, G. F. Linton, S. Brenner, J. M. Sechler, P. M. Murphy, and H. L. Malech. 2005. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome. Exp. Hematol. 33:460-468.
101. Keresztes, G., H. Mutai, and S. Heller. 2003. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 4:24. (Pubitemid 39565284)
102. Kim, P. W., Z. Y. Sun, S. C. Blacklow, G. Wagner, and M. J. Eck. 2003. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science 301:1725-1728. (Pubitemid 37174366)
103. Kim, Y. M., W. Reed, W. Wu, P. A. Bromberg, L. M. Graves, and J. M. Samet. 2006. Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L1028-L1035.
104. King, L. E., F. Osati-Ashtiani, and P. J. Fraker. 2002. Apoptosis plays a distinct role in the loss of precursor lymphocytes during zinc deficiency in mice. J. Nutr. 132:974-979. (Pubitemid 34495446)
105. Kirchner, H., and H. Ruhl. 1970. Stimulation of human peripheral lymphocytes by Zn2+ in vitro. Exp. Cell Res. 61:229-230.
106. Kitamura, H., H. Morikawa, H. Kamon, M. Iguchi, S. Hojyo, T. Fukada, S. Yamashita, T. Kaisho, S. Akira, M. Murakami, and T. Hirano. 2006. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 7:971-977.
107. Koshiol, J., L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith. 2008. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am. J. Epidemiol. 168:123-137.
108. Krawczyk, E., J. A. Hanover, R. Schlegel, and F. A. Suprynowicz. 2008. Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem. Biophys. Res. Commun. 371:684-688.
109. Kurima, K., Y. Yang, K. Sorber, and A. J. Griffith. 2003. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 82:300-308. (Pubitemid 36952303)
110. Kutler, D. I., V. B. Wreesmann, A. Goberdhan, L. Ben-Porat, J. Satagopan, I. Ngai, A. G. Huvos, P. Giampietro, O. Levran, K. Pujara, R. Diotti, D. Carlson, L. A. Huryn, A. D. Auerbach, and B. Singh. 2003. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J. Natl. Cancer Inst. 95:1718-1721.
111. Kyo, S., D. J. Klumpp, M. Inoue, T. Kanaya, and L. A. Laimins. 1997. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J. Gen. Virol. 78:401-411.
112. Laffort, C., F. Le Deist, M. Favre, S. Caillat-Zucman, I. Radford-Weiss, M. Debre, S. Fraitag, S. Blanche, M. Cavazzana-Calvo, G. de Saint Basile, J. P. de Villartay, S. Giliani, G. Orth, J. L. Casanova, C. Bodemer, and A. Fischer. 2004. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 363:2051-2054. (Pubitemid 38781108)
113. Laity, J. H., B. M. Lee, and P. E. Wright. 2001. Zinc finger proteins: new insights into structural and functional diversity. Curr. Opin. Struct. Biol. 11:39-46.
114. Langmade, S. J., R. Ravindra, P. J. Daniels, and G. K. Andrews. 2000. The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J. Biol. Chem. 275:34803-34809.
115. 2+ ions in host-virus interactions. J. Virol. 82:11486-11494.
116. Lazarczyk, M., C. Pons, J. A. Mendoza, P. Cassonnet, Y. Jacob, and M. Favre. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42.
117. Le Deist, F., C. Laffort, G. Orth, C. Bodemer, and A. Fischer. 2005. Severe combined immunodeficiency: susceptibility to HPV? Med. Sci. (Paris) 21:125-127. (In French.)
118. Leverrier, S., D. Bergamaschi, L. Ghali, A. Ola, G. Warnes, B. Akgul, K. Blight, R. Garcia-Escudero, A. Penna, A. Eddaoudi, and A. Storey. 2007. Role of HPV E6 proteins in preventing UVB-induced release of proapoptotic factors from the mitochondria. Apoptosis 12:549-560. (Pubitemid 46318909)
119. Li, J. J., J. S. Rhim, R. Schlegel, K. H. Vousden, and N. H. Colburn. 1998. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 16:2711-2721. (Pubitemid 28279336)
120. Lin, R. S., C. Rodriguez, A. Veillette, and H. F. Lodish. 1998. Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. J. Biol. Chem. 273:32878-32882.
121. Lipari, F., G. A. McGibbon, E. Wardrop, and M. G. Cordingley. 2001. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40:1196-1204. (Pubitemid 32142880)
122. Liuzzi, J. P., J. A. Bobo, L. A. Lichten, D. A. Samuelson, and R. J. Cousins. 2004. Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis. Proc. Natl. Acad. Sci. USA 101:14355-14360.
123. Liuzzi, J. P., and R. J. Cousins. 2004. Mammalian zinc transporters. Annu. Rev. Nutr. 24:151-172.
124. Longworth, M. S., and L. A. Laimins. 2004. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J. Virol. 78:3533-3541. (Pubitemid 38568295)
125. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
126. Lu, X. M., S. Monnier-Benoit, L. Z. Mo, S. Y. Xu, J. L. Pretet, Z. Liu, D. A. Vuitton, and C. Mougin. 2008. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur. J. Surg. Oncol. 34:765-770.
127. Lutzner, M., O. Croissant, M. F. Ducasse, H. Kreis, J. Crosnier, and G. Orth. 1980. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J. Investig. Dermatol. 75:353-356.
128. Lutzner, M. A. 1978. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull. Cancer 65:169-182.
129. Mack, D. H., and L. A. Laimins. 1991. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA 88:9102-9106.
130. Majewski, S., M. Favre, G. Orth, and S. Jablonska. 1998. Is human papillomavirus type 5 the putative autoantigen involved in psoriasis? J. Investig. Dermatol. 111:541-542.
131. Majewski, S., N. Hunzelmann, R. Nischt, B. Eckes, L. Rudnicka, G. Orth, T. Krieg, and S. Jablonska. 1991. TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis. J. Investig. Dermatol. 97:862-867.
132. Majewski, S., and S. Jablonska. 1997. Human papillomavirus-associated tumors of the skin and mucosa. J. Am. Acad. Dermatol. 36:659-685.
133. Mann, J. J., and P. J. Fraker. 2005. Zinc pyrithione induces apoptosis and increases expression of Bim. Apoptosis 10:369-379. (Pubitemid 40603490)
134. May, M., K. Grassmann, H. Pfister, and P. G. Fuchs. 1994. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J. Virol. 68:3612-3619.
135. McIntyre, M. C., M. G. Frattini, S. R. Grossman, and L. A. Laimins. 1993. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 67:3142-3150. (Pubitemid 23143683)
136. Medina-Martinez, O., V. Vallejo, M. C. Guido, and A. Garcia-Carranca. 1997. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol. Carcinog. 19:83-90.
137. Mendoza, J. A., Y. Jacob, P. Cassonnet, and M. Favre. 2006. Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor - signaling pathway by binding to SMAD3. J. Virol. 80:12420-12424. (Pubitemid 44904395)
138. Moerman, M., V. G. Danielides, C. S. Nousia, F. Van Wanzeele, R. Forsyth, and H. Vermeersch. 2001. Recurrent focal epithelial hyperplasia due to HPV13 in an HIV-positive patient. Dermatology 203:339-341. (Pubitemid 34045200)
139. Mohr, I. J., R. Clark, S. Sun, E. J. Androphy, P. MacPherson, and M. R. Botchan. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694-1699. (Pubitemid 120031873)
140. Molano, M., A. Van den Brule, M. Plummer, E. Weiderpass, H. Posso, A. Arslan, C. J. Meijer, N. Munoz, and S. Franceschi. 2003. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am. J. Epidemiol. 158:486-494.
141. Munger, K., and P. M. Howley. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228. (Pubitemid 35351540)
142. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
143. Munoz, N., X. Castellsague, A. B. de Gonzalez, and L. Gissmann. 2006. HPV in the etiology of human cancer. Vaccine 24(Suppl. 3):1-10.
144. Narisawa-Saito, M., and T. Kiyono. 2007. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 98:1505-1511. (Pubitemid 47308443)
145. Notarangelo, L., J. L. Casanova, A. Fischer, J. Puck, F. Rosen, R. Seger, and R. Geha. 2004. Primary immunodeficiency diseases: an update. J. Allergy Clin. Immunol. 114:677-687.
146. Obalek, S., M. Favre, J. Szymanczyk, J. Misiewicz, S. Jablonska, and G. Orth. 1992. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J. Investig. Dermatol. 98:936-941.
147. Offord, E. A., and P. Beard. 1990. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol. 64:4792-4798. (Pubitemid 20329798)
148. Ohana, E., D. Segal, R. Palty, D. Ton-That, A. Moran, S. L. Sensi, J. H. Weiss, M. Hershfinkel, and I. Sekler. 2004. A sodium zinc exchange mechanism is mediating extrusion of zinc in mammalian cells. J. Biol. Chem. 279:4278-4284.
149. Ohlenschlager, O., T. Seiboth, H. Zengerling, L. Briese, A. Marchanka, R. Ramachandran, M. Baum, M. Korbas, W. Meyer-Klaucke, M. Durst, and M. Gorlach. 2006. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 25:5953-5959. (Pubitemid 44477289)
150. Oldak, M., H. Smola, M. Aumailley, F. Rivero, H. Pfister, and S. Smola-Hess. 2004. The human papillomavirus type 8 E2 protein suppresses β-4-integrin expression in primary human keratinocytes. J. Virol. 78:10738-10746. (Pubitemid 39258399)
151. Orth, G. 1987. Epidermodysplasia verruciformis, p. 199-243. In N. P. Salzman and P. M. Howley (ed.), the papovaviridae: the papillomaviruses. Plenum Press, New York, NY.
152. Orth, G. 2006. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol. 18:362-374.
153. Orth, G. 2005. Human papillomaviruses associated with epidermodysplasia
154. Orth, G. 1999. Papillomaviruses - human (papovaviridae): general features, p. 1105-1114. In A. Granoff and R. G. Webster (ed.), Encyclopedia of Virology, 2nd ed. Academic Press, London, United Kingdom.
155. Orth, G., M. Favre, F. Breitburd, O. Croissant, S. Jablonska, and S. Obalek. 1980. Epidermodysplasia verruciformis: a model for the role of papillomaviruses in human cancer. Cold Spring Harb. Conf. Cell Prolif. 7:259-282.
156. Outten, C. E., and T. V. O'Halloran. 2001. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science 292:2488-2492. (Pubitemid 32605687)
157. Palefsky, J. M. 2007. HPV infection in men. Dis. Markers 23:261-272. (Pubitemid 47018218)
158. Palmiter, R. D., and S. D. Findley. 1995. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:639-649.
159. Patel, A. S., M. R. Karagas, M. Pawlita, T. Waterboer, and H. H. Nelson. 2008. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int. J. Cancer 122:2377-2379.
160. Patrick, J., J. Michael, M. N. Golden, B. E. Golden, and P. J. Hilton. 1978. Effect of zinc on leucocyte sodium transport in vitro. Clin. Sci. Mol. Med. 54:585-587.
161. Peitsaro, P., B. Johansson, and S. Syrjanen. 2002. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40:886-891.
162. Peto, M., I. Tolle-Ersu, H. G. Kreysch, and G. Klock. 1995. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J. Gen. Virol. 76:1945-1958.
163. Pett, M., and N. Coleman. 2007. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J. Pathol. 212:356-367. (Pubitemid 47099012)
164. Pfefferle, R., G. P. Marcuzzi, B. Akgul, H. U. Kasper, F. Schulze, I. Haase, C. Wickenhauser, and H. Pfister. 2008. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J. Investig. Dermatol. 128:2310-2315.
165. Pfister, H., P. G. Fuchs, S. Majewski, S. Jablonska, I. Pniewska, and M. Malejczyk. 2003. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch. Dermatol. Res. 295:273-279.
166. Praetorius, F. 1997. HPV-associated diseases of oral mucosa. Clin. Dermatol. 15:399-413.
167. Prasad, A. S. 1998. Zinc and immunity. Mol. Cell. Biochem. 188:63-69.
168. Prawer, S. E., F. Pass, J. C. Vance, L. J. Greenberg, E. J. Yunis, and A. S. Zelickson. 1977. Depressed immune function in epidermodysplasia verruciformis. Arch. Dermatol. 113:495-499.
169. Premoli-De-Percoco, G., J. P. Cisternas, J. L. Ramirez, and I. Galindo. 1993. Focal epithelial hyperplasia: human-papillomavirus-induced disease with a genetic predisposition in a Venezuelan family. Hum. Genet. 91:386-388.
170. Prusty, B. K., and B. C. Das. 2005. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer 113:951-960. (Pubitemid 40096875)
171. Purdie, K. J., T. Surentheran, J. C. Sterling, L. Bell, J. M. McGregor, C. M. Proby, C. A. Harwood, and J. Breuer. 2005. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J. Investig. Dermatol. 125:98-107.
172. Pyrhonen, S., S. Jablonska, S. Obalek, and E. Kuismanen. 1980. Immune reactions in epidermodysplasia verruciformis. Br. J. Dermatol. 102:247-254.
173. Radtke, F., R. Heuchel, O. Georgiev, M. Hergersberg, M. Gariglio, Z. Dembic, and W. Schaffner. 1993. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J. 12:1355-1362. (Pubitemid 23112790)
174. Rajagopalan, K., J. Bahru, D. S. Loo, C. H. Tay, K. N. Chin, and K. K. Tan. 1972. Familial epidermodysplasia verruciformis of Lewandowsky and Lutz. Arch. Dermatol. 105:73-78.
175. Ramoz, N., L. A. Rueda, B. Bouadjar, M. Favre, and G. Orth. 1999. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J. Investig. Dermatol. 112:259-263.
176. Ramoz, N., L. A. Rueda, B. Bouadjar, L. S. Montoya, G. Orth, and M. Favre. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32:579-581.
177. Ramoz, N., A. Taieb, L. A. Rueda, L. S. Montoya, B. Bouadjar, M. Favre, and G. Orth. 2000. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J. Investig. Dermatol. 114:1148-1153.
178. Reeves, W. C., S. S. Ruparelia, K. I. Swanson, C. S. Derkay, A. Marcus, and E. R. Unger. 2003. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 129:976-982.
179. Regan, J. A., and L. A. Laimins. 2008. Bap31 is a novel target of the human papillomavirus E5 protein. J. Virol. 82:10042-10051.
180. Reh, H., and H. Pfister. 1990. Human papillomavirus type 8 contains cisactive positive and negative transcriptional control sequences. J. Gen. Virol. 71:2457-2462.
181. Rink, L., and P. Gabriel. 2001. Extracellular and immunological actions of zinc. Biometals 14:367-383. (Pubitemid 34066639)
182. Ristriani, T., Y. Nomine, M. Masson, E. Weiss, and G. Trave. 2001. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J. Mol. Biol. 305:729-739.
183. Roberts, S., I. Ashmole, T. M. Sheehan, A. H. Davies, and P. H. Gallimore. 1994. Human papillomavirus type 1 E4 protein is a zinc-binding protein. Virology 202:865-874. (Pubitemid 24254900)
184. Rodriguez, M. I., M. E. Finbow, and A. Alonso. 2000. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19:3727-3732. (Pubitemid 30621177)
185. Roth, E. J., B. Kurz, L. Liang, C. L. Hansen, C. T. Dameron, D. R. Winge, and D. Smotkin. 1992. Metal thiolate coordination in the E7 proteins of human papilloma virus 16 and cottontail rabbit papilloma virus as expressed in Escherichia coli. J. Biol. Chem. 267:16390-16395.
186. Ruhl, H., and H. Kirchner. 1978. Monocyte-dependent stimulation of human T cells by zinc. Clin. Exp. Immunol. 32:484-488.
187. Sastre-Garau, X., M. Favre, J. Couturier, and G. Orth. 2000. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J. Gen. Virol. 81:1983-1993.
188. Schaper, I. D., G. P. Marcuzzi, S. J. Weissenborn, H. U. Kasper, V. Dries, N. Smyth, P. Fuchs, and H. Pfister. 2005. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 65:1394-1400. (Pubitemid 40270167)
189. Schiffman, M., P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907. (Pubitemid 47371147)
190. Schiffman, M., R. Herrero, R. Desalle, A. Hildesheim, S. Wacholder, A. C. Rodriguez, M. C. Bratti, M. E. Sherman, J. Morales, D. Guillen, M. Alfaro, M. Hutchinson, T. C. Wright, D. Solomon, Z. Chen, J. Schussler, P. E. Castle, and R. D. Burk. 2005. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84. (Pubitemid 40725441)
191. Schneider-Maunoury, S., O. Croissant, and G. Orth. 1987. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J. Virol. 61:3295-3298. (Pubitemid 17137683)
192. Sekler, I., S. L. Sensi, M. Hershfinkel, and W. F. Silverman. 2007. Mechanism and regulation of cellular zinc transport. Mol. Med. 13:337-343.
193. Seo, S. R., S. A. Chong, S. I. Lee, J. Y. Sung, Y. S. Ahn, K. C. Chung, and J. T. Seo. 2001. Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J. Neurochem. 78:600-610. (Pubitemid 32729988)
194. Shannon, P., A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498-2504. (Pubitemid 37428274)
195. Smirnova, I. V., D. C. Bittel, R. Ravindra, H. Jiang, and G. K. Andrews. 2000. Zinc and cadmium can promote rapid nuclear translocation of metal response element-binding transcription factor-1. J. Biol. Chem. 275:9377-9384.
196. Smith, J. S., L. Lindsay, B. Hoots, J. Keys, S. Franceschi, R. Winer, and G. M. Clifford. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632. (Pubitemid 46986496)
197. Soto, U., C. Denk, P. Finzer, K. J. Hutter, H. zur Hausen, and F. Rosl. 2000. Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition. Int. J. Cancer 86:811-817.
198. Srodon, M., M. H. Stoler, G. B. Baber, and R. J. Kurman. 2006. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am. J. Surg. Pathol. 30:1513-1518.
199. Stoppler, M. C., S. W. Straight, G. Tsao, R. Schlegel, and D. J. McCance. 1996. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223:251-254. (Pubitemid 26302066)
200. Straight, S. W., B. Herman, and D. J. McCance. 1995. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69:3185-3192.
201. Straight, S. W., P. M. Hinkle, R. J. Jewers, and D. J. McCance. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532. (Pubitemid 23215930)
202. Struijk, L., J. N. Bouwes Bavinck, P. Wanningen, E. van der Meijden, R. G. Westendorp, J. Ter Schegget, and M. C. Feltkamp. 2003. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J. Investig. Dermatol. 121:1531-1535.
203. Stunkel, W., and H. U. Bernard. 1999. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J. Virol. 73:1918-1930. (Pubitemid 29098093)
204. Sutton, B. C., R. A. Allen, W. E. Moore, and S. T. Dunn. 2008. Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva. Mod. Pathol. 21:345-354.
205. Tanaka, Y., S. Shiozawa, I. Morimoto, and T. Fujita. 1989. Zinc inhibits pokeweed mitogen-induced development of immunoglobulin-secreting cells through augmentation of both CD4 and CD8 cells. Int. J. Immunopharmacol. 11:673-679.
206. Teresa, G., A. Anna, P. Maria, J. Zofia, and B. Gerard. 2002. Carp erythrocyte lipids as a potential target for the toxic action of zinc ions. Toxicol. Lett. 132:57-64.
207. Thierry, F., and P. M. Howley. 1991. Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol. 3:90-100.
208. Tindle, R. W. 2002. Immune evasion in human papillomavirus-associated cervical cancer. Nat. Rev. Cancer 2:59-65.
209. Tottey, S., K. J. Waldron, S. J. Firbank, B. Reale, C. Bessant, K. Sato, T. R. Cheek, J. Gray, M. J. Banfield, C. Dennison, and N. J. Robinson. 2008. Protein-folding location can regulate manganese-binding versus copper- or zinc-binding. Nature 455:1138-1142.
210. Trottier, H., and E. L. Franco. 2006. The epidemiology of genital human papillomavirus infection. Vaccine 24(Suppl. 1):S1-S15.
211. Trottier, H., and E. L. Franco. 2006. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am. J. Manag. Care 12:S462-S472.
212. Tsai, T. C., and S. L. Chen. 2003. The biochemical and biological functions of human papillomavirus type 16 E5 protein. Arch. Virol. 148:1445-1453.
213. Tsao, Y. P., L. Y. Li, T. C. Tsai, and S. L. Chen. 1996. Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. J. Virol. 70:7535-7539. (Pubitemid 26339058)
214. Underbrink, M. P., H. L. Howie, K. M. Bedard, J. I. Koop, and D. A. Galloway. 2008. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 82:10408-10417. (Pubitemid 352691188)
215. Ushikai, M., M. J. Lace, Y. Yamakawa, M. Kono, J. Anson, T. Ishiji, S. Parkkinen, N. Wicker, M. E. Valentine, I. Davidson, et al. 1994. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68:6655-6666.
216. Valentine, R. A., K. A. Jackson, G. R. Christie, J. C. Mathers, P. M. Taylor, and D. Ford. 2007. ZnT5 variant B is a bidirectional zinc transporter and mediates zinc uptake in human intestinal Caco-2 cells. J. Biol. Chem. 282:14389-14393.
217. van de Nieuwenhof, H. P., I. A. van der Avoort, and J. A. de Hullu. 2008. Review of squamous premalignant vulvar lesions. Crit. Rev. Oncol. Hematol. 68:131-156.
218. van Zeeburg, H. J., P. J. Snijders, T. Wu, E. Gluckman, J. Soulier, J. Surralles, M. Castella, J. E. van der Wal, J. Wennerberg, J. Califano, E. Velleuer, R. Dietrich, W. Ebell, E. Bloemena, H. Joenje, C. R. Leemans, and R. H. Brakenhoff. 2008. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J. Natl. Cancer Inst. 100:1649-1653.
219. Verstraeten, S. V., M. P. Zago, G. G. MacKenzie, C. L. Keen, and P. I. Oteiza. 2004. Influence of zinc deficiency on cell-membrane fluidity in Jurkat, 3T3 and IMR-32 cells. Biochem. J. 378:579-587. (Pubitemid 38367247)
220. von Knebel Doeberitz, M. 2002. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur. J. Cancer 38:2229-2242.
221. Wang, K., B. Zhou, Y. M. Kuo, J. Zemansky, and J. Gitschier. 2002. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71:66-73.
222. Warner, G. L., and D. A. Lawrence. 1988. The effect of metals on IL-2-related lymphocyte proliferation. Int. J. Immunopharmacol. 10:629-637.
223. Watanabe, S., H. Sato, A. Furuno, and K. Yoshiike. 1992. Changing the spacing between metal-binding motifs decreases stability and transforming activity of the human papillomavirus type 18 E7 oncoprotein. Virology 190:872-875.
224. Weissenborn, S. J., I. Nindl, K. Purdie, C. Harwood, C. Proby, J. Breuer, S. Majewski, H. Pfister, and U. Wieland. 2005. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J. Investig. Dermatol. 125:93-97.
225. Wellinghausen, N., H. Kirchner, and L. Rink. 1997. The immunobiology of zinc. Immunol. Today 18:519-521. (Pubitemid 27488099)
226. Wetzler, M., M. Talpaz, E. S. Kleinerman, A. King, Y. O. Huh, J. U. Gutterman, and R. Kurzrock. 1990. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am. J. Med. 89:663-672.
227. Wilson, V. G., M. West, K. Woytek, and D. Rangasamy. 2002. Papillomavirus E1 proteins: form, function, and features. Virus Genes 24:275-290. (Pubitemid 34615304)
228. Winer, R. L., Q. Feng, J. P. Hughes, S. O'Reilly, N. B. Kiviat, and L. A. Koutsky. 2008. Risk of female human papillomavirus acquisition associated with first male sex partner. J. Infect. Dis. 197:279-282.
229. Winer, R. L., S. K. Lee, J. P. Hughes, D. E. Adam, N. B. Kiviat, and L. A. Koutsky. 2003. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am. J. Epidemiol. 157:218-226.
230. Woodman, C. B., S. Collins, H. Winter, A. Bailey, J. Ellis, P. Prior, M. Yates, T. P. Rollason, and L. S. Young. 2001. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831-1836. (Pubitemid 32539115)
231. Yamamoto, Y., J. M. Huibregtse, and P. M. Howley. 1997. The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41:263-266. (Pubitemid 27175356)
232. Yamasaki, S., K. Sakata-Sogawa, A. Hasegawa, T. Suzuki, K. Kabu, E. Sato, T. Kurosaki, S. Yamashita, M. Tokunaga, K. Nishida, and T. Hirano. 2007. Zinc is a novel intracellular second messenger. J. Cell Biol. 177:637-645. (Pubitemid 46799835)
233. You, J., J. L. Croyle, A. Nishimura, K. Ozato, and P. M. Howley. 2004. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117:349-360. (Pubitemid 38534541)
234. Zavattaro, E., B. Azzimonti, M. Mondini, M. De Andrea, C. Borgogna, V. Dell'Oste, M. Ferretti, S. Nicola, G. Cappellano, A. Carando, G. Leigheb, S. Landolfo, U. Dianzani, and M. Gariglio. 2008. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J. Investig. Dermatol. 128:732-735.
235. Zheng, Z. M., and C. C. Baker. 2006. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 11:2286-2302.
236. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
237. Zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384:260-265.